|
|
|
|
|
|
|
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 109, Issue 1 63-71, Copyright © 1996 by Company of Biologists
JOURNAL ARTICLES |
R Williams, GW Stamp, C Gilbert, M Pignatelli and EN Lalani
Department of Histopathology, Royal Postgraduate Medical School, London, UK.
We describe the first model system employing human pS2 gene transfer and expression in a non-pS2-expressing cell line, mouse mammary adenocarcinoma 410.4, in order to analyse the potential effect of human trefoil peptide pS2 in glandular epithelium. Two selected clones, AA4 and AD4, were established and shown to have incorporated the pS2 cDNA sequence into the genome, express pS2 containing transcript and produce the pS2 peptide. When grown in 3-D collagen gels both transfectants show striking morphological changes compared to the vector control clone (VA5). VA5 forms large cohesive spherical aggregates with rare coarse spicular outgrowths, accompanied by prominent hyalinised extracellular matrix deposition. pS2 transfectants form poorly cohesive, stellate colonies with very little or no matrix deposition, radiating long cords composed of single elongated cells, an effect previously observed in other cell lines with hepatocyte growth factor. pS2 transfection had no demonstrable effect on proliferation and this is not a morphogenetic phenomenon, as tubulogenesis is not seen. Motility assays suggest that the pS2 'dispersant' effect in collagen gels is due to an increase in cell motility. There were no measurable alterations in either E-cadherin expression or E-cadherin-dependent cell-cell aggregation. pS2 may play a role in maintenance and restitution of mucosal integrity by accelerating migration/dispersion.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  F Gadal, A Starzec, C Bozic, C Pillot-Brochet, S Malinge, V Ozanne, J Vicenzi, L Buffat, G Perret, F Iris, et al. Integrative analysis of gene expression patterns predicts specific modulations of defined cell functions by estrogen and tamoxifen in MCF7 breast cancer cells J. Mol. Endocrinol., February 1, 2005; 34(1): 61 - 75. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. P. Paulsen, M. Hinz, U. Schaudig, A. B. Thale, and W. Hoffmann TFF Peptides in the Human Efferent Tear Ducts Invest. Ophthalmol. Vis. Sci., November 1, 2002; 43(11): 3359 - 3364. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Graness, C. E. Chwieralski, D. Reinhold, L. Thim, and W. Hoffmann Protein Kinase C and ERK Activation Are Required for TFF- peptide-stimulated Bronchial Epithelial Cell Migration and Tumor Necrosis Factor-alpha -induced Interleukin-6 (IL-6) and IL-8 Secretion J. Biol. Chem., May 17, 2002; 277(21): 18440 - 18446. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S S Poulsen, J Thulesen, L Christensen, E Nexo, and L Thim Metabolism of oral trefoil factor 2 (TFF2) and the effect of oral and parenteral TFF2 on gastric and duodenal ulcer healing in the rat Gut, October 1, 1999; 45(4): 516 - 522. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W M WONG, R POULSOM, and N A WRIGHT Trefoil peptides Gut, June 1, 1999; 44(6): 890 - 895. [Full Text] [PDF]
|
|
|
|
|
|
S S Poulsen, J Thulesen, E Nexo, and L Thim Distribution and metabolism of intravenously administered trefoil factor 2/porcine spasmolytic polypeptide in the rat Gut, August 1, 1998; 43(2): 240 - 247. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Efstathiou and M. Pignatelli Modulation of Epithelial Cell Adhesion in Gastrointestinal Homeostasis Am. J. Pathol., August 1, 1998; 153(2): 341 - 347. [Full Text] [PDF]
|
|
